UPDATE: Tango Therapeutics Inc. (TNGX) PT Lowered to $16 at Goldman Sachs

Go back to UPDATE: Tango Therapeutics Inc. (TNGX) PT Lowered to $16 at Goldman Sachs

Tango Therapeutics Inc. (TNGX) PT Lowered to $14 at Guggenheim

March 28, 2022 11:26 AM EDT

Guggenheim analyst Charles Zhu lowered the price target on Tango Therapeutics Inc. (NASDAQ: TNGX) to $14.00 (from $16.00) while maintaining a Buy rating.... More